Bridge City Capital, LLC Corcept Therapeutics Inc Transaction History

Bridge City Capital, LLC

$289 Million
Q2 2024

A detailed history of Bridge City Capital, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Bridge City Capital, LLC holds 49,237 shares of CORT stock, worth $2.16 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

49,237

Previous 49,638 0.81%

Holding current value

$2.16 Million

Previous $1.25 Million 27.92%

% of portfolio

0.55%

Previous 0.47%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$22.21 - $34.48 $8,906 - $13,826	-401 Reduced 0.81%	49,237 $1.6 Million
Q1 2024 Apr 12, 2024	BUY	$21.1 - $27.46 $8,144 - $10,599	386 Added 0.78%	49,638 $1.25 Million
Q4 2023 Feb 13, 2024	BUY	$24.82 - $32.88 $143,136 - $189,618	5,767 Added 13.26%	49,252 $1.6 Million
Q3 2023 Nov 15, 2023	SELL	$21.97 - $33.8 $376,719 - $579,568	-17,147 Reduced 28.28%	43,485 $1.18 Million
Q2 2023 Aug 16, 2023	BUY	$21.44 - $25.15 $750 - $880	35 Added 0.06%	60,632 $1.35 Million
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $4,358 - $5,554	-227 Reduced 0.37%	60,597 $1.31 Million
Q4 2022 Jan 25, 2023	SELL	$19.95 - $29.96 $8,578 - $12,882	-430 Reduced 0.7%	60,824 $1.24 Million
Q3 2022 Nov 08, 2022	SELL	$24.7 - $29.12 $557,330 - $657,063	-22,564 Reduced 26.92%	61,254 $1.57 Million
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $2,582 - $3,769	-149 Reduced 0.18%	83,818 $1.99 Million
Q1 2022 May 18, 2022	SELL	$16.53 - $25.21 $7,289 - $11,117	-441 Reduced 0.52%	83,967 $1.89 Million
Q4 2021 Jan 20, 2022	SELL	$17.1 - $23.34 $256 - $350	-15 Reduced 0.02%	84,408 $1.67 Million
Q3 2021 Nov 10, 2021	SELL	$19.68 - $22.53 $443,095 - $507,262	-22,515 Reduced 21.05%	84,423 $1.66 Million
Q2 2021 Aug 11, 2021	SELL	$19.97 - $24.43 $71,372 - $87,312	-3,574 Reduced 3.23%	106,938 $2.35 Million
Q1 2021 Apr 28, 2021	SELL	$23.49 - $30.56 $26,473 - $34,441	-1,127 Reduced 1.01%	110,512 $2.63 Million
Q4 2020 Feb 12, 2021	SELL	$16.78 - $27.3 $19,448 - $31,640	-1,159 Reduced 1.03%	111,639 $2.92 Million
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $273,347 - $438,321	21,938 Added 24.14%	112,798 $1.96 Million
Q2 2020 Jul 15, 2020	BUY	$11.0 - $18.26 $999,460 - $1.66 Million	90,860 New	90,860 $1.53 Million

Others Institutions Holding CORT

# of Institutions

311

Shares Held

88.3M

Call Options Held

1.07M

Put Options Held

973K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.71B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridge City Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridge City Capital, LLC with notifications on news.

Account

Bridge City Capital, LLC Corcept Therapeutics Inc Transaction History